CMP: 724

Novartis India Limited manufactures pharmaceuticals and animal healthcare products to protect health, cure disease and improve well-being. The Company sells prescription drugs as well as generic and OTC medicines. Novartis is currently organized into three divisions: Pharmaceuticals, Sandoz - which comprises of their activities in generic prescription drugs and Consumer Health.

Novartis India is a good bet in mid-cap pharma space. Its currently trading at a P/E of 15 with decent dividend yields of over 1% in the last 12 months. Minimal liabilities with good cash & cash equivalents. Revenues have risen steadily from 542 Crores to 746 Crores in the last 5 years. Profits have risen steadily from 88 Crores to 147 Crores in the same period. NPM has risen smartly from 16% towards 20% over 5 years. Buy and hold for long term gains.